January 30, 2019
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Read More
January 30, 2019
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe
Read More
January 30, 2019
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe
Read More
January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Read More
January 30, 2019
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
Read More
January 30, 2019
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders
Read More
December 10, 2018
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Read More
December 10, 2018
Post Authorisation Safety Study With Raxone in LHON Patients
Read More
Load More
X